The DOI matches its Crossref record.
Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Abstract
This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic patients are at high risk of cardiovascular events, particularly of coronary heart disease by about 3-fold [67,68].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [67]
In the citing paper
“T2DM is associated with a two-fold higher risk of CAD and ischaemic stroke”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
In the citing paper
“and a two-to four-fold higher CAD-and stroke-related mortality.139 -141”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
Citations
Cited by
Sorted by citations
Items 501–600 of 999
Chen, J.-H., Michiue, T., Inamori-Kawamoto, O., Ikeda, S., Ishikawa, T., & Maeda, H. (2015) · Legal Medicine · doi:10.1016/j.legalmed.2015.08.004 · Cited by 21
“Serum glucose is regulated within a narrow range by multiple factors in physiological conditions, but the disorders involving hyperglycemia in diabetes mellitus cause serious complications, including systemic vascular disorder leading to ischemic heart disease, cerebrovascular disease and nephropathy, as well as sever…”
BackgroundControlling Diabetes After Liver Transplantation
Alvarez‐Sotomayor, D., Satorres, C., Rodríguez-Medina, B., Herrero, I., de la Mata, M., Serrano, T., Rodríguez‐Perálvarez, M., D’Avola, D., Lorente, S., Rubín, Á., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001399 · Cited by 21
How do high glycemic load diets influence coronary heart disease?
Mathews, M. J., Liebenberg, L., & Mathews, E. H. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0001-x · Cited by 21
“It is thus conceivable that the reductions in CHD risk achieved could be greater than expected due to the increased risk for CHD associated with type 2 diabetes mellitus [188].”
BackgroundAdvances in the treatment of prediabetes
Matfin, G., & Pratley, R. E. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810366429 · Cited by 20
“Risk of developing cardiovascular disease A large number of studies have demonstrated that diabetes per se markedly increases risk for CVD [Kannel and McGee, 1979].”
BackgroundLepojärvi, E. S., Piira, O.-P., Kiviniemi, A. M., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.038 · Cited by 21
Caixàs, A., Pérez, A., Ordóñez‐Llanos, J., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1459 · Cited by 21
“The risk of cardiovascular disease is increased in NIDDM patients (1), but the precise reasons for this excess of risk are not known.”
BackgroundWu, D., Doods, H. N., & Stassen, J. M. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000239691.69346.6a · Cited by 21
Manuel‐y‐Keenoy, B. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.005 · Cited by 21
“Patients with diabetes mellitus have a two- to four-fold increased risk of both developing and dying from cardiovascular disease [1,2].”
BackgroundAlmeda‐Valdés, P., Ramos, D. C., Mehta, R., Gomez-Perez, F. J., & Aguilar-Salinas, C. A. (2010) · Current Diabetes Reviews · doi:10.2174/157339910790442646 · Cited by 21
“The UKPDS risk engine had an overall better performance than the Framingham equation in terms of predicting coronary heart disease rates [23, 24].”
MethodCoronary heart disease in type 2 diabetes melittus in Isfahan, Iran
Janghorbani, M., Amini, M., & Tavassoli, A. (2006) · Acta Cardiologica · doi:10.2143/ac.61.1.2005135 · Cited by 21
Hyperglycemia Promotes Microinflammation as Evaluated by C-Reactive Protein in the Very Elderly
Fukuhara, M., Matsumura, K., Wakisaka, M., Takata, Y., Sonoki, K., Fujisawa, K., Ansai, T., Akifusa, S., Fujii, K., Iida, M., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.1868 · Cited by 21
“Diabetes is one of the most important cardiovascular risk factors, and it is closely associated with systemic atherosclerosis (14, 15).”
BackgroundUchida, T., Shimizu, M., Sakai, Y., Nakano, T., Hara, K., Takebayashi, K., Inoue, T., Node, K., Inukai, T., Takayanagi, K., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.024 · Cited by 20
“People with type 2 diabetes mellitus have a 2- to 4-fold higher risk of CVD than nondiabetic individuals [36,37].”
BackgroundSobenin, I. A., Tertov, V. V., Orekhov, A. N., et al. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90055-8 · Cited by 21
The Effect of Glycemic Control on the Incidence of Macrovascular Complications of Type 2 Diabetes
Stern, M. P. (1998) · Archives of Family Medicine · doi:10.1001/archfami.7.2.155 · Cited by 21
“9.(3) The corresponding relative risks in the Rancho Bernardo Study in southern California were 1.”
BackgroundPPAR Ligands and Clinical Trials: Cardiovascular Risk Reduction with Fibrates
Robins, S. J. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800403 · Cited by 21
Rogowicz‐Frontczak, A., Araszkiewicz, A., Piłaciński, S., et al. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.29526 · Cited by 20
Gong, R., Chen, M., Zhang, C., Chen, M., & Li, H. (2017) · Diagnostic Pathology · doi:10.1186/s13000-017-0630-7 · Cited by 20
“T2D has been associated with increased risk of cardiovascular disease and death [4, 5].”
BackgroundChu, A., Han, L., Roifman, I., Lee, D. S., Green, M., Jacklin, K. M., Walker, J. D., Sutherland, R., Khan, S., Frymire, E., et al. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.190899 · Cited by 22
Cardiovascular Risk/Disease in Type 2 Diabetes Mellitus
Román, G., & Stoian, A. P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97422 · Cited by 26
Gastrointestinal-related Uremic Toxins in Peritoneal Dialysis: A Pilot Study with a 5-year Follow-up
Lin, C., Pan, C., Chuang, C., et al. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.09.007 · Cited by 20
Women with Diabetes Have Poorer Control of Blood Pressure Than Men
Duggirala, M. K., Cuddihy, R. M., Cuddihy, M.-T. M., Nyman, M., Naessens, J. M., & Pankratz, V. S. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.418 · Cited by 20
Langemo, D. K., Thompson, P. A., Hunter, S. M., et al. (2008) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000323506.53154.4a · Cited by 20
“An individual with DM has a heel ulcer occur 4 times more often than an individual without DM.(49) Neuropathy (pathological changes in the peripheral nervous system) is poorly understood, but is seen frequently with age and DM.”
BackgroundInfluentialWasilewski, R., Ubara, E. O., & Klonizakis, M. (2016) · Microvascular Research · doi:10.1016/j.mvr.2016.05.001 · Cited by 21
“Green tea (GT) and particularly its high quantities of catechins have been the subject of extensive research and have subsequently been associated with a reduction in CVD risk makers by improving endothelial functioning (Alexopoulos et al. 2008).”
InfluentialFeng, W., Li, Z., Guo, W., Fan, X., Zhou, F., Zhang, K., Ou, C., Huang, F., & Chen, M. (2020) · Diabetes Care · doi:10.2337/dc20-0838 · Cited by 19
Lixandru, D., Mohora, M., Coman, A. L., Stoian, I. A.-M., Gils, C. V., Aerts, P., & Manuel‐y‐Keenoy, B. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000298879 · Cited by 20
“Diabetes mellitus (DM) is associated with a 2- to 4-fold increased morbidity and mortality from cardiovascular disease [”
BackgroundKarabağ, T., Kaya, A., Temizhan, A., et al. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0245-7 · Cited by 20
“Type 2 diabetes mellitus (T2DM) patients are at increased risk for atherosclerotic diseases such as coronary heart disease, cerebrovascular disease and lower extremity occlusive vascular diseases that cause high mortality and morbidity [1, 2].”
BackgroundFrioud, A., Comte-Perret, S., Nguyen, S., Berger, M. M., Ruchat, P., & Ruiz, J. C. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.06.008 · Cited by 21
“DM is associated with a threefold risk of cardiovascular omplications [1].”
BackgroundDerosa, G., Avanzini, M. A., Geroldi, D., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.273 · Cited by 20
“0001 24 [19–33] 21 [11–28] 0.”
Chukwuma, C., & Tuomilehto, J. O. (1998) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679800500102 · Cited by 20
Should All Diabetic Patients Be Treated With a Statin?
Kamari, Y., Bitzur, R., Cohen, H., Shaish, A., & Harats, D. (2009) · Diabetes Care · doi:10.2337/dc09-s344 · Cited by 22
“The Framingham cohort (8), and more recent data, have established the notion that diabetes is associated with a twoto fourfold increased risk of both CHD and stroke (9–11).”
MethodType 2 diabetes and atherosclerosis
Donnelly, R., & Davis, K. R. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00019.x · Cited by 20
Early Detection Of Asymptomatic Coronary Artery Disease In Patients With Type 2 Diabetes Mellitus
Yoo, W. S., Kim, H. J., Kim, D.-H., Lee, M., & Chung, H.-K. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.3.183 · Cited by 20
“CAD risk for those with type 2 DM is as great as that associated with a previous history of myocardial infarction [1-3].”
BackgroundCamacho, P. M., Pitale, S., & Abraira, C. (2000) · Drugs & Aging · doi:10.2165/00002512-200017060-00004 · Cited by 19
“[3-9] Because of these complications, the yearly mortality rate of patients with diabetes mellitus is 2- to 3-fold higher than that of age-matched controls.”
BackgroundScreening for Diabetes in General Practice
Lawrence, J., & Robinson, A. (2003) · Preventive Cardiology · doi:10.1111/j.1520-037x.2003.01662.x · Cited by 20
Risk Factors for Atherosclerotic Aortoiliac Occlusive Disease
Cacoub, P., & Godeau, P. (1993) · Annals of Vascular Surgery · doi:10.1007/bf02002897 · Cited by 20
Tahir, A., Martinez, P. J., Ahmad, F., Fisher‐Hoch, S. P., McCormick, J. B., Gay, J. L., Mirza, S., & Chaudhary, S. U. (2021) · Scientific Reports · doi:10.1038/s41598-021-93445-9 · Cited by 20
Adapting Technological Interventions to Meet the Needs of Priority Populations
Linke, S., Larsen, B. A., Marquez, B., Mendoza-Vasconez, A. S., & Marcus, B. H. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.03.001 · Cited by 20
Carew, A. S., Mekary, R. A., Kirkland, S., Theou, O., Siddiqi, F. S., Urquhart, R., George, M. M., Blanchard, C. M., Biggs, M. L., Djoussé, L., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac087 · Cited by 26
RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction
Cornelius, V. A., Naderi‐Meshkin, H., Kelaini, S., & Margariti, A. (2022) · Cells · doi:10.3390/cells11162494 · Cited by 21
Emodin-6-O-β-d--glucoside Inhibits High-Glucose-Induced Vascular Inflammation
Lee, W., Ku, S., Lee, D., et al. (2013) · Inflammation · doi:10.1007/s10753-013-9741-9 · Cited by 19
Johansson, M., Lind, M. M., Jansson, J., Fhärm, E., & Johansson, L. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.03.015 · Cited by 19
Sas, K. M., Lin, J., Wang, C.-H., Zhang, H., Saha, J., Rajendiran, T. M., Soni, T., Nair, V., Eichinger, F. H., Kretzler, M., et al. (2021) · Metabolomics · doi:10.1007/s11306-021-01816-0 · Cited by 19
Masseau, I., & Bowles, D. K. (2015) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2015.811073 · Cited by 19
Influence of Diabetes and/or Myocardial Infarction on Prevalence of Abnormal T‐Wave Alternans
Martin, D. T., Shoraki, A., Nesto, R. W., et al. (2009) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2009.00325.x · Cited by 19
Pérez, A., Jacks, R., Arora, V. K., & Spanheimer, R. G. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00389.x · Cited by 19
Balteskard, L., Brox, J. H., & Østerud, B. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90087-b · Cited by 19
Adeniyi, A., Folsom, A. R., Brancati, F. L., Desvorieux, M., Pankow, J. S., & Taylor, H. A. (2002) · PubMed Central · Cited by 19
Rogowicz‐Frontczak, A., Araszkiewicz, A., Piłaciński, S., et al. (2012) · PubMed · doi:10.5114/aoms.2012.29404 · Cited by 18
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19349 · Cited by 18
Tanwar, O., Deora, G. S., Tanwar, L., Kumar, G., Janardhan, S., Alam, M. M., Shaquiquzzaman, M., & Akhter, M. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2118-7 · Cited by 18
“Poor eating habits and lack of exercise imposemany other problems, such as increased risk of coronary artery disease, stroke, hypertension, nephropathy, peripheral vascular disease, and retinopathy [2, 3].”
BackgroundNardi, E., Palermo, A., Mulè, G., Cusimano, P., Cottone, S., & Cerasola, G. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.96 · Cited by 18
Seldin, M. M., Kim, E. D., Romay, M. C., Li, S., Rau, C. D., Wang, J., Krishnan, K. C., Wang, Y., Deb, A., & Lusis, A. J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2016 · Cited by 18
“Large population-based studies have suggested an association between elevated blood glucose and heart failure, especially in the context of type 2 diabetes (7, 27, 30, 62, 64).”
Comparative risk of new‐onset diabetes mellitus for antihypertensive drugs: A network meta‐analysis
Li, Z., Li, Y., Liu, Y., Xu, W., & Wang, Q. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13108 · Cited by 17
“The selection of articles was further narrowed down by defining the following inclusion criteria: (1) randomized controlled trail design; (2) diagnosis of NOD confirmed by American Diabetes Association criteria,13 diabetic symptoms, glucose levels on fasting or oral glucose tolerance testing; and (3) clearly described…”
BackgroundMethodInfluentialCoronary risk equivalence of diabetes assessed by SPECT-MPI
Morales, D. C., Bhavnani, S. P., Ahlberg, A. W., Pullatt, R. C., Katten, D. M., Polk, D. M., & Heller, G. V. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1114-6 · Cited by 18
Zhang, F., Wang, K., Gao, F., Xuan, Y., Liu, X., & Zhang, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632375 · Cited by 18
“It is predicted that the prevalence of patients with DM will increase to 5.4% by the year 2025 and will affect about 300 million people worldwide (Kannel and McGee, 1979; King et al., 1998; Kanters et al., 1999).”
BackgroundInfluentialCastelblanco, E., Sarrias, M., Betriu, À., Soldevila, B., Barranco-Altirriba, M., Franch‐Nadal, J., Valdivielso, J. M., Bermúdez-López, M., Groop, P., Fernández, E., et al. (2021) · Aging · doi:10.18632/aging.203615 · Cited by 19
“Our finding confirms that individuals with diabetes have a higher susceptibility for CV events than their counterparts without diabetes and, in line with other studies, highlights the relevance of hypertension, smoking, and age in this population [1, 5, 43, 44].”
Kajikuri, J., Watanabe, Y., Ito, Y., Ito, R., Yamamoto, T., & Itoh, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00348.x · Cited by 18
“, 2002) and that diabetes is an important risk factor for the development of coronary artery disease (Kannel and McGee, 1979).”
BackgroundMulvey, C. K., McNeill, A. M., Girman, C. J., Churchill, T. W., Terembula, K., Ferguson, J. F., Shah, R. D., Mehta, N. N., Qasim, A., Rickels, M. R., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1880 · Cited by 19
“However, because diabetes confers cardiovascular risk beyond traditional risk factors, the degree of insulin resistance may independently affect macrovascular complications (11).”
BackgroundWeerakoon, B. S., & Osuga, T. (2015) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2015.811075 · Cited by 18
“Moreover, patients with type 2 diabetes mellitus are more likely to develop CAD compared to non-diabetic patients [29].”
BackgroundCubedo, J., Padró, T., García-Arguinzonis, M., Vilahur, G., Miñambres, I., Pou, J. M., Ybarra, J., & Badimón, L. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p057513 · Cited by 18
Farhangi, M. A., Moradi, F., Najafi, M., & Jafarabadi, M. A. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.011 · Cited by 18
Insulin resistance and vessel endothelial function.
van Oostrom, A. J. H. H. M., Cabezas, M. C., & Rabelink, T. J. (2002) · Europe PMC (PubMed Central) · Cited by 18
Jackson, E. A., Sivasubramian, R., Spencer, F. A., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123837 · Cited by 18
Little, P. J., Allen, T. J., Hashimura, K., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00201-2 · Cited by 18
Gorter, P. M., Visseren, F. L. J., Algra, A., van der Graaf, Y., & on behalf of the SMART Study Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02323.x · Cited by 18
NT‐proBNP in normoalbuminuric patients with Type 2 diabetes mellitus
Andersen, N. H., Poulsen, S. H., Knudsen, S. T., Heickendorff, L., & Mogensen, C. E. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01396.x · Cited by 18
Laskarzewski, P. M., Rao, D. C., Glueck, C. J., et al. (1984) · Genetic Epidemiology · doi:10.1002/gepi.1370010406 · Cited by 18
The Effect of Diabetes and Impaired Glucose Tolerance on Mortality in Malta
Tuomilehto, J. O., Schranz, A., Aldana, D., et al. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb02015.x · Cited by 18
Fontbonne, A. (1991) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610070307 · Cited by 17
Practical aspects of preventing and managing atherosclerotic disease in post-menopausal women
Sullivan, J. M. (1996) · European Heart Journal · doi:10.1093/eurheartj/17.suppl_d.32 · Cited by 18
Cardiovascular risk in type 2 diabetes
Standl, E. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.0010s2024.x · Cited by 18
Imaging Atherosclerosis in Diabetes: Current State
Rahmani, S., Nakanishi, R., & Budoff, M. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0799-2 · Cited by 18
Insulin and cardiovascular disease: biomarker or association?
Jandeleit-Dahm, K. A. M., & Gray, S. P. (2012) · Diabetologia · doi:10.1007/s00125-012-2729-4 · Cited by 18
“As in the Framingham study [17–19], the excess mortality could not be explained by age, blood pressure, cholesterol and cigarette smoking alone.”
BackgroundCardiovascular protective properties of incretin-based therapies in type 2 diabetes
Şimşek, S., & de Galan, B. E. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283590b8f · Cited by 16
Growth hormone exacerbates diabetic renal damage in male but not female rats
Whitney, J. L., Bilkan, C. M., Sandberg, K. L., et al. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-12 · Cited by 17
“Periodic acid Schiff-stained, paraffin-embedded kidney sections (3 μm) were examined using a Nikon Eclipse E600 (Tokyo, Japan) light microscope to assess the glomerulosclerotic index (GSI), as previously described [20].”
BackgroundMethodNasser, M., Clere, N., Botelle, L., Javellaud, J., Oudart, N., Faure, S., & Achard, J. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-40 · Cited by 17
“Background Diabetes mellitus is a major cause of morbidity and mortality worldwide and is associated with an increased risk of cardiovascular disease [1].”
BackgroundChen, D., Li, Y., Mao, C., Tseng, C., Hsieh, C., Hung, M., Chu, P., Wang, C., Wen, M., Cherng, W., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13078 · Cited by 17
Inhibitory effect of atorvastatin on AGE-induced HCAEC apoptosis by upregulating HSF-1 protein
Li, Y., Li, J., Cui, L., Lai, Y., Yao, Y., Zhang, Y., Pang, X., Wang, J., & Liu, X. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.03.035 · Cited by 17
Meneilly, G. S., & Tessier, D. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-715-4_12 · Cited by 17
Yao, T., Lu, W., Zhu, J. H., Jin, X., Ma, G., Wang, Y., Meng, S., Zhang, Y., Li, Y., & Shen, C. (2015) · PubMed Central · Cited by 17
Ahmad, J., Ahmned, F., Siddiqui, M. A., Khan, A., Katyal, P., Hameed, B., & Ahmad, I. (2007) · PubMed · Cited by 17
The epidemiology of atherosclerosis and its risk factors among Native Americans
Galloway, J. M. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0095-1 · Cited by 17
“It is well-known that individuals with diabetes are at a much higher risk than are nondiabetic persons for developing CVD of all types, including coronary, cerebral, and peripheral arterial disease [ 15 ,16].”
BackgroundTakeuchi, Y., Okayama, N., Imaeda, K., Okouchi, M., Omi, H., Imai, S., Akao, M., Takeda, Y., Hukutomi, T., & Itoh, M. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.02.002 · Cited by 17
Burdon, K. P., Bento, J. L., Langefeld, C. D., Campbell, J. K., Carr, J. J., Wagenknecht, L. M., Herrington, D. M., Freedman, B. I., Rich, S. S., & Bowden, D. W. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0058 · Cited by 17
Yu, Y., Li, W., Xu, L., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124353 · Cited by 16
“The risk of cardiovascular disease in diabetic patients is 2-3 times higher than that in healthy people (2, 4, 6), which is related to the thrombogenic environment and the earlier and more severe vascular pathological change (7, 8).”
BackgroundUnderstanding and treating hypertension in diabetic populations.
Volpe, M., Battistoni, A., Savoia, C., & Tocci, G. (2015) · PubMed Central · doi:10.3978/j.issn.2223-3652.2015.06.02 · Cited by 19
“infarction, ischemic stroke and congestive heart failure, but also microvascular complications, such as retinopathy, nephropathy and peripheral artery disease (3).”
BackgroundTocci, G., Figliuzzi, I., Presta, V., Halabieh, N. A. E., Citoni, B., Coluccia, R., Battistoni, A., Ferrucci, A., & Volpe, M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.078 · Cited by 16
“In the setting of clinical practice, this assessment is mostly based on the use of risk score charts and calculators, which have been developed and tested in large epidemiological surveys and observational clinical studies performed during the last decades [4-10].”
BackgroundMethodDiabetes, colorectal cancer and cyclooxygenase 2 inhibition
Smith, C., McKay, G., & Fisher, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01726.x · Cited by 16
Hodžić, A., Ribault, V., Maragnès, P., et al. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0025 · Cited by 16
“Type 1 diabetes is associated with excess mortality in young adults due to premature cardiovascular events[2], including heart failure[3,4].”
BackgroundA study on diabetic foot and its association with peripheral artery disease
Muthiah, A., Kandasamy, R., Nagulan, S., et al. (2017) · International Surgery Journal · doi:10.18203/2349-2902.isj20170937 · Cited by 16
“Framingham heart study revealed that 20% of symptomatic patients with PAD had diabetes but this probably underestimates the prevalence as most people with PAD are asymptomatic.2 Diabetes, smoking, hypertension, advanced age, hyperlipidemia, elevated Creactive protein, apolipoprotein, lipoprotein (a), fibrinogen and pl…”
BackgroundInfluentialFibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
Maatman, B. T., Schmeisser, G., & Kreutz, R. P. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4543065 · Cited by 15
The metabolic syndrome in type 2 diabetes: When does it matter?
Wong, J., Molyneaux, L. M., Constantino, M., Twigg, S. M., & Yue, D. K. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00565.x · Cited by 15
Burdon, K. P., Langefeld, C. D., Wagenknecht, L. E., Carr, J. J., Freedman, B. I., Herrington, D. M., & Bowden, D. W. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01777.x · Cited by 16
Risum, Ø., Abdelnoor, M., Svennevig, J. L., et al. (1996) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(96)80293-4 · Cited by 16
O’Neil, C. E., Nicklas, T. A., Suzuki, S., Myers, L., Johnson, C., & Berenson, G. S. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199712000-00005 · Cited by 16
Vaur, L., Danchin, N., Hanania, G., Cambou, J., Lablanche, J. M., Blanchard, D., Clerson, P., & Guéret, P. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70033-2 · Cited by 16
“D iabetes mellitus is associated with a two- to four- fold increase in the risk of coronary heart disease [1-4].”
BackgroundKoschinsky, T., B�nting, C. E., R�tter, R., & Gries, F. A. (1985) · Diabetologia · doi:10.1007/bf00282237 · Cited by 16
“A major role has been attributed to the abnormal metabolic environment in both Type 1 (insulin-dependent) and Type 2 diabetes [8-10], although the nature of any factor(s) with additional growth-stimulating effect in diabetic sera has remained uncertain.”
BackgroundAspirin therapy is still underutilized among patients with type 2 diabetes
Leitão, C. B., Krahe, A. L., Nabinger, G. B., et al. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000600006 · Cited by 15
“Nevertheless, the specialists position statements need to guide the physicians based in the best available evidence and, at least until now, it indicates that the DM patient is in high risk of CHD and needs to be treated in the same way as that group of patients.”
BackgroundInfluentialKikuchi, C., Kajikuri, J., Hori, E., Nagami, C., Matsunaga, T., Kimura, K., & Itoh, T. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00975 · Cited by 13
Relationship between Serum Cholesterol Efflux Capacity and Glucose Intolerance in Japanese-Americans
Kubota, M., Nakanishi, S., Hirano, M., Maeda, S., Yoneda, M., Awaya, T., Yamane, K., & Kohno, N. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24315 · Cited by 15
Metadata
- Authors
- Kannel, W. B., & McGee, D. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1979-03-01
- Volume
- 2
- Issue
- 2
- Pages
- 120-126
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2059537042
- Cited by
- 1,203
- References
- 0
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 40 · 2020: 31 · 2019: 39 · 2018: 41 · 2017: 38 · 2016: 43 · 2015: 55 · 2014: 50 · 2013: 35 · 2012: 36
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, impaired glucose tolerance, cardiovascular risk, coronary artery disease, peripheral vascular disease, stroke, cardiovascular mortality, heart failure, sex differences, cardiovascular risk factors, Framingham cohort
- MeSH terms
- Age Factors, Aged, Cardiovascular Diseases, Female, Glucose Tolerance Test, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk, Sex Factors, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
